Over the past many years, the amount of individuals referred for allogeneic hematopoietic mobile transplantation has dropped drastically,133 nevertheless the process should be proposed to younger/suit patients in whom BCR/BCL2 inhibitor cure fails, especially in Those people with TP53 PAGCOR meny